Journey Medical (DERM) filed a shelf registration statement Thursday with the US Securities and Exchange Commission for the potential sale of up to $150 million in securities, to be offered from time to time.
The filing covers common stock, preferred stock, debt securities, warrants and units.
The company plans to use the net proceeds for general corporate purposes, with any unused funds temporarily invested or used to reduce short-term debt, it added.
Shares of Journey Medical were down nearly 2% in after-hours trading.